Drug Information

Drug General Information
Drug ID
D0YW9C
Former ID
DNC008780
Drug Name
1-benzyl-2,3-dimethyl-1H-indole-7-carboxylic acid
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529963]
Structure
Download
2D MOL

3D MOL
Formula
C18H17NO2
Canonical SMILES
CC1=C(N(C2=C1C=CC=C2C(=O)O)CC3=CC=CC=C3)C
InChI
1S/C18H17NO2/c1-12-13(2)19(11-14-7-4-3-5-8-14)17-15(12)9-6-10-16(17)18(20)21/h3-10H,11H2,1-2H3,(H,20,21)
InChIKey
NSKDMNCONIAVGH-UHFFFAOYSA-N
PubChem Compound ID
44564825
Target and Pathway
Target(s) Fatty acid-binding protein, adipocyte Target Info Inhibitor [529963]
KEGG Pathway PPAR signaling pathway
NetPath Pathway TCR Signaling Pathway
Pathway Interaction Database AP-1 transcription factor network
Reactome Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis
Transcriptional regulation of white adipocyte differentiation
WikiPathways Lipid digestion, mobilization, and transport
Transcriptional Regulation of White Adipocyte Differentiation
References
Ref 529963Bioorg Med Chem Lett. 2009 Mar 15;19(6):1745-8. Epub 2009 Jan 30.N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors.
Ref 529963Bioorg Med Chem Lett. 2009 Mar 15;19(6):1745-8. Epub 2009 Jan 30.N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.